MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

Search

Neogen Corp

Slēgts

SektorsVeselības aprūpe

9.17 -1.5

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.06

Max

9.36

Galvenie mērījumi

By Trading Economics

Ienākumi

-52M

-16M

Pārdošana

16M

225M

Peļņas marža

-7.087

Darbinieki

2,974

EBITDA

-66M

23M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

-2.16% downside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 8. apr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

461M

2B

Iepriekšējā atvēršanas cena

10.67

Iepriekšējā slēgšanas cena

9.17

Ziņu noskaņojums

By Acuity

64%

36%

323 / 361 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Neogen Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. janv. 19:05 UTC

Galvenie tirgus virzītāji

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

2026. g. 13. janv. 23:41 UTC

Tirgus saruna

Nikkei May Rise on Japan Election Hopes -- Market Talk

2026. g. 13. janv. 23:41 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 13. janv. 23:33 UTC

Tirgus saruna

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

2026. g. 13. janv. 23:13 UTC

Iegādes, apvienošanās, pārņemšana

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

2026. g. 13. janv. 23:10 UTC

Iegādes, apvienošanās, pārņemšana

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

2026. g. 13. janv. 23:03 UTC

Tirgus saruna

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

2026. g. 13. janv. 21:50 UTC

Iegādes, apvienošanās, pārņemšana

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

2026. g. 13. janv. 21:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2026. g. 13. janv. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

2026. g. 13. janv. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

2026. g. 13. janv. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

2026. g. 13. janv. 21:15 UTC

Iegādes, apvienošanās, pārņemšana

VERSANT Completes Acquisition Of Free TV Networks >VSNT

2026. g. 13. janv. 21:08 UTC

Iegādes, apvienošanās, pārņemšana

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

2026. g. 13. janv. 20:39 UTC

Tirgus saruna

Silver Settles at Another New High -- Market Talk

2026. g. 13. janv. 20:21 UTC

Tirgus saruna

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

2026. g. 13. janv. 20:17 UTC

Tirgus saruna

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

2026. g. 13. janv. 19:08 UTC

Iegādes, apvienošanās, pārņemšana

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

2026. g. 13. janv. 19:03 UTC

Peļņas

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

2026. g. 13. janv. 18:50 UTC

Peļņas

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

2026. g. 13. janv. 17:54 UTC

Tirgus saruna

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

2026. g. 13. janv. 17:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Global Equities Roundup: Market Talk

2026. g. 13. janv. 17:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

2026. g. 13. janv. 17:49 UTC

Tirgus saruna

Analysts Call For Potential Record Ethanol Output -- Market Talk

2026. g. 13. janv. 17:38 UTC

Tirgus saruna

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

2026. g. 13. janv. 17:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 13. janv. 17:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 13. janv. 17:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2026. g. 13. janv. 17:19 UTC

Tirgus saruna

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

2026. g. 13. janv. 17:15 UTC

Tirgus saruna

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Salīdzinājums

Cenas izmaiņa

Neogen Corp Prognoze

Cenas mērķis

By TipRanks

-2.16% uz leju

Prognoze 12 mēnešiem

Vidējais 9.5 USD  -2.16%

Augstākais 12 USD

Zemākais 6.5 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Neogen Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

4 ratings

2

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

5.17 / 5.99Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

323 / 361 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat